Research on pharmacokinetics in weightless environment

Abstract

Abstract:

Space pharmacokinetics is an important part of aerospace medicine. The change of pharmacokinetics caused by the change of physiological and biochemical function of weightlessness in space, is one of the key factors influencing the use of medicine. This article reviewed the research progress including experimental models, the effects on the absorption, distribution, metabolism and excretion of drugs, and the influencing factors of pharmacokinetics of weightlessness, which may provide some reference for space pharmacokinetics.

Key words: weightless, pharmacokinetics

CLC Number:

R969.1

WANG Xiaoqing, ZHOU Jiezhao, CHENG Zeneng, JIANG Dejian. Research on pharmacokinetics in weightless environment[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 709-712.

References

［1］Greenleaf JE. Mechanisms for negative water balance during weightlessness: immersion or bed rest［J］? Physiologist, 1985, 28:S38-39.
［2］Pestov ID, Pokrovsky AV. Controlled water immersion as a model of weightlessness［J］. Physiologist, 1987, 30(1 Suppl): S125-128.
［3］Watenpaugh DE. Analogs of microgravity: head-down tilt and water immersion［J］. J Appl Physiol, 2016, 120(8): 904-914.
［4］Pitts GC, Bull LS, Oyama J. Effect of chronic centrifugation on body composition in the rat［J］. Am J Physiol, 1972, 223(5): 1044-1048.
［5］Bedford TG, Tipton CM. Lower body negative pressure in the tranquilized rat［J］. Aviat Space Environ Med, 1985, 56(8): 786-790.
［6］Witzmann FA, Kim DH, Fitts RH. Hindlimb immobilization: length-tension and contractile properties of skeletal muscle［J］. J Appl Physiol Respir Environ Exerc Physiol, 1982, 53(2): 335-345.
［7］Musacchia XJ, Deavers DR, Meininger GA, et al. A model for hypokinesia: effects on muscle atrophy in the rat［J］. J Appl Physiol Respir Environ Exerc Physiol, 1980, 48(3): 479-486.
［8］Wronski TJ, Morey-Holton ER. Skeletal response to simulated weightlessness: a comparison of suspension techniques［J］. Aviat Space Environ Med, 1987, 58(1): 63-68.
［9］Feldman S, Brunner LJ. Small animal model of weightlessness for pharmacokinetic evaluation［J］. J Clin Pharmacol, 1994, 34(6): 677-683.
［10］Morey-Holton ER, Globus RK. Hindlimb unloading rodent model: technical aspects［J］. J Appl Physiol, 2002, 92(4): 1367-1377.
［11］Morey ER, Sabelman EE, Turner RT, et al. A new rat model simulating some aspects of space flight［J］. Physiologist, 1979, 22(6) : S23-24 .
［12］Sun LW, Blottner D, Luan HQ, et al. Bone and muscle structure and quality preserved by active versus passive muscle exercise on a new stepper device in 21 days tail-suspended rats［J］. J Musculoskelet Neuronal Interact, 2013, 13(2): 166-177.
［13］Yu B, Yu D, Cao L, et al. Simulated microgravity using a rotary cell culture system promotes chondrogenesis of human adipose-derived mesenchymal stem cells via the p38 MAPK pathway［J］. Biochem Biophys Res Commun, 2011, 414(2): 412-418.
［14］Cintron NM，Lane HW，Leach CS. Metabolic consequences of fluid shifts induced by microgravity［J］. Physiologist, 1990, 33(1 Suppl):S16-19.
［15］Gandia P, Bareille MP, Saivin S, et al. Influence of simulated weightlessness on the oral pharmacokinetics of acetaminophen as a gastric emptying probe in man: a plasma and a saliva study［J］. J Clin Pharmacol, 2003, 43(11): 1235-1243.
［16］Idkaidek N, Arafat T. Effect of microgravity on the pharmacokinetics of ibuprofen in humans［J］. J Clin Pharmacol, 2011, 51(12): 1685-1689.
［17］陈英，杨春敏，韩全利，等. 模拟失重对大鼠血浆 ghrelin, VIP 和胃肠动力的影响［J］. 胃肠病学和肝病学杂志，2012，21(1): 55-58.
［18］Ying C, Chunmin Y, Qingsen L, et al. Effects of simulated weightlessness on tight junction protein occludin and Zonula Occluden-1 expression levels in the intestinal mucosa of rats［J］. J Huazhong Univ Sci Technolog Med Sci, 2011, 31(1): 26-32.
［19］Chen Y, Yang C, Mao G, et al. Effects of simulated weightlessness on the intestinal mucosal barrier of rats［J］. Advances in Space Res, 2011, 48(2): 395-402.
［20］Vaquer S, Cuyàs E, Rabadán A, et al. Active transmembrane drug transport in microgravity: a validation study using an ABC transporter model［J］. F1000 Res, 2014, 3:201.
［21］郭志峰，高建义，王宝珍，等．头低位(-20°) 限制活动7d对兔庆大霉素药代动力学的影响［J］．航天医学与医学工程，1999，12(5) :333-337．
［22］Chowdhury P,Soulsby ME,Pasley JN.Distribution of 3H-nicotine in rat tissues under the influence of simulated microgravity［J］.Biomed Environ Sci,1999,12(2) :103-109.
［23］Schuck EL, Grant M, Derendorf H. Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers［J］.J Clin Pharmacol, 2005, 45(7) : 822-831.
［24］Brunner LJ, DiPiro JT, Feldman S. Antipyrine pharmacokinetics in the tail-suspended rat model［J］. J Pharmacol Exp Ther, 1995, 274(1): 345-352.
［25］Pavy-Le Traon A, Guell A, Saivin S, et al. The use of medicaments in space--therapeutic measures and potential impact of pharmacokinetics due to weightlessness［J］. ESA J, 1993, 18(1): 33-50.
［26］Saivin S, Traon A, Cornac A, et al. Impact of a four-day head-down tilt (-6 degrees) on lidocaine pharmacokinetics used as probe toevaluate hepatic blood flow［J］. J Clin Pharmacol, 1995, 35(7): 697-704.
［27］Brunner LJ, DiPiro JT, Feldman S. Antipyrine pharmacokinetics in the tail-suspended rat model［J］. J Pharmacol Exp Ther, 1995, 274(1): 345-352.
［28］Merrill AH, Wang E, Jones DP, et al. Hepatic function in rats after spaceflight: effects on lipids, glycogen, and enzymes［J］. Am J Physiol, 1987, 252(2): R222-R226.
［29］Merrill AH, Hoel M, Wang E, et al. Altered carbohydrate, lipid, and xenobiotic metabolism by liver from rats flown on Cosmos 1887［J］. FASEB J, 1990, 4(1): 95-100.
［30］Moskaleva N, Moysa A, Novikova S, et al. Spaceflight Effects on Cytochrome P450 Content in Mouse Liver［J］. PloS one, 2015, 10(11): e0142374.
［31］Wei B, Abobo CV, Ma J, et al. Gender differences in pharmacokinetics of antipyrine in a simulated weightlessness rat model［J］. Aviat Space Environ Med, 2012, 83(1): 8-13.
［32］Nicogossian AE. Overall physiological response to space flight［J］. Space Physiology and Medicine, 1989: 139-153.
［33］梁力. 基于生理药动学模型的异丙嗪在模拟失重大鼠体内的处置研究［D］. 第四军医大学，2015.
［34］刘彦卿，洪燕君，曾苏.代谢性药物-药物相互作用的研究进展［J］. 浙江大学学报(医学版), 2009, 38(2): 215-224.
［35］张艳，郝海平，王广基.尿苷二磷酸葡萄糖醛酸转移酶介导的药物相互作用的研究进展［J］. 中国临床药理学与治疗学, 2011, 16(4): 447-454.

[1]	WU Yujie, ZHAO Chengcheng, XI Qing. Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033.
[2]	LI Kun, LI Lulu, LI Nannan, HU Weihong, ZHOU Jianchao. Effects of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 767-774.
[3]	HE Xueru, LI Ying, MA Yinling, FU Yuhao, XUN Xuejiao, DONG Zhanjun. Pharmacokinetic interaction study between sorafenib and dapagliflozin in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 498-507.
[4]	HUANG Zhiwei, LI Yi, XU Xiaoyong, ZHANG Lei, SHEN Yifeng, LI Huafang. Comparison of calculation results of five population pharmacokinetic analysis tools [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 525-535.
[5]	LI Mengxue, HE Jie, YU Xiaxia, HU Linlin, SHAO Hua. Research progress in population pharmacokinetics of rituximab [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 468-474.
[6]	YAN Qiangyong, XIANG Daxiong, ZHU Ronghua, YANG Lingfeng, YANG Xiding, LI Jingjing, FAN Xiao, LIU Sai, XIONG Shoujun, FANG Pingfei. Bioequivalence study of cinacalcet hydrochloride tablets in healthy Chinese volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 171-177.
[7]	LIU Lu, SHI Yufei, HE Qingfeng, XU Fengyan, WANG Kun, CAI Weimin, XIANG Xiaoqiang. Application of population modeling analysis to evaluate the impact of gene polymorphism on drug PK/PD [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1275-1282.
[8]	ZHOU Jiating, ZHANG Xuan, XIE Zilan, LI Zhi. Interactions and clinical significance of gut microbiota and levothyroxine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1307-1314.
[9]	LI Xuejing, JIANG Jinping, LI Sining, WAN Linfei, ZHOU Xiangxiang, YANG Lian, LAN Ke. A bioequivalence study of generic and brand clozapine in schizophrenic patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1121-1130.
[10]	WU Lili, LIANG Zhi, HUANG Siyong, WANG Yan. Effect of augmented renal clearance (ARC) on the pharmacokinetics, efficacy, and safety of vancomycin in patients with infective endocarditis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1139-1145.
[11]	MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling. Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918.
[12]	DAI Jingyi, WANG Jingjing, ZHANG Jing, YU Jicheng, LI Nanyang, HUANG Zhiwei. Clinical application and research progress of inhaled methoxyflurane [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 808-813.
[13]	PAN Shu, WU Yijin, ZHANG Sasa, WANG Qihai, LUO Tingting, YIN Qin. Pharmacokinetics of methotrexate mediated by organic anion transporter 3 in adjuvant induced arthritis rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 516-525.
[14]	WU Juan, WANG Zhiqiang, ZHOU Renpeng, YANG Jingjing, QIN Huiling, ZHANG Qian, LU Chao, HU Wei. Bioequivalence trial of fasting oral sorafenib tosylate tablets in healthy Chinese subjects [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 281-286.
[15]	ZHANG Jinhua, LIU Maobai, CAI Mingzhi, ZHENG Yingli, LAO Haiyan, XIANG Qian, DU Liping, ZHU Zhu, DONG Jing, ZUO Xiaocong, LI Xingang, SHANG Dewei, CHEN Bing, YE Yanrong, WANG Yuzhu, GAO Jianjun, ZHANG Jian, CHEN Wansheng, XIE Haitang, JIAO Zheng. Model informed precision dosing of warfarin: China expert consensus report (2022 version) [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1201-1212.